These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15341712)

  • 1. Drug delivery to the small intestine.
    Friend DR
    Curr Gastroenterol Rep; 2004 Oct; 6(5):371-6. PubMed ID: 15341712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Oral Delivery of Bisphosphonate by Novel Absorption Enhancers: Improvement of Intestinal Absorption of Alendronate by N-Acyl Amino Acids and N-Acyl Taurates and Their Absorption-Enhancing Mechanisms.
    Nakaya Y; Takaya M; Hinatsu Y; Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    J Pharm Sci; 2016 Dec; 105(12):3680-3690. PubMed ID: 27771051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption.
    Steffansen B; Nielsen CU; Brodin B; Eriksson AH; Andersen R; Frokjaer S
    Eur J Pharm Sci; 2004 Jan; 21(1):3-16. PubMed ID: 14706808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-mediated active targeting for enhanced oral absorption.
    Zhang X; Wu W
    Drug Discov Today; 2014 Jul; 19(7):898-904. PubMed ID: 24631680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral drug delivery utilizing intestinal OATP transporters.
    Tamai I
    Adv Drug Deliv Rev; 2012 May; 64(6):508-14. PubMed ID: 21824501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
    Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K
    Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein drug oral delivery: the recent progress.
    Lee HJ
    Arch Pharm Res; 2002 Oct; 25(5):572-84. PubMed ID: 12433186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption sites of orally administered drugs in the small intestine.
    Murakami T
    Expert Opin Drug Discov; 2017 Dec; 12(12):1219-1232. PubMed ID: 28920464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies.
    Shao B; Cui C; Ji H; Tang J; Wang Z; Liu H; Qin M; Li X; Wu L
    Drug Deliv; 2015; 22(6):740-7. PubMed ID: 24670090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres.
    Reineke JJ; Cho DY; Dingle YT; Morello AP; Jacob J; Thanos CG; Mathiowitz E
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13803-8. PubMed ID: 23922388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
    Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
    Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
    Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
    Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of intestinal transporters and metabolism in the oral absorption of drug and prodrugs.
    Varma MV
    Curr Drug Metab; 2010 Nov; 11(9):715. PubMed ID: 21244346
    [No Abstract]   [Full Text] [Related]  

  • 16. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption.
    del Amo EM; Heikkinen AT; Mönkkönen J
    Eur J Pharm Sci; 2009 Feb; 36(2-3):200-11. PubMed ID: 19063964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A; Declèves X; Bouzom F; Ball K; Marques C; Treton X; Pocard M; Valleur P; Bouhnik Y; Panis Y; Scherrmann JM; Mouly S
    Mol Pharm; 2010 Oct; 7(5):1596-607. PubMed ID: 20604570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional absorption of L-carnitine after oral administration in rats: evaluation of absorption site and dose dependency.
    Matsuda K; Yuasa H; Watanabe J
    Biol Pharm Bull; 1998 Jul; 21(7):752-5. PubMed ID: 9703262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Gas Empowered Drug Delivery system for peptide delivery in the small intestine.
    Sadeghi AM; Avadi MR; Ejtemaimehr Sh; Abashzadeh Sh; Partoazar A; Dorkoosh F; Faghihi M; Rafiee-Tehrani M; Junginger HE
    J Control Release; 2009 Feb; 134(1):11-7. PubMed ID: 19014985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.